Clinical Trial Update: Study of Arimoclomol in Inclusion Body Myositis (IBM) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of arimoclomol in Inclusion Body Myositis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inclusion Body Myositis

Drugs mentioned

• Arimoclomol (arimoclomol)

Snippet

Sponsor: ZevraDenmark | Conditions: Inclusion Body Myositis | Phase 2 | Status: COMPLETED | Results posted: 2023-05-10